Aspen Pharmacare PE Ratio 2017-2023 | APNHY
Current and historical p/e ratio for Aspen Pharmacare (APNHY) from 2017 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Aspen Pharmacare PE ratio as of April 18, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Aspen Pharmacare PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
|
0.00 |
|
nan |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$5.172B |
$2.296B |
|
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
|
